Joon Seong Park

Summary

Affiliation: Ajou University
Country: Korea

Publications

  1. pmc Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
    Yu Ri Kim
    Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
    J Hematol Oncol 5:49. 2012
  2. pmc Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy
    Yu Ri Kim
    Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul 120 752, Korea
    J Hematol Oncol 4:34. 2011

Detail Information

Publications2

  1. pmc Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
    Yu Ri Kim
    Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
    J Hematol Oncol 5:49. 2012
    ..The objective of this study was to identify prognostic factors for survival in patients with primary diffuse large B-cell lymphoma (DLBCL) of the adrenal gland...
  2. pmc Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy
    Yu Ri Kim
    Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul 120 752, Korea
    J Hematol Oncol 4:34. 2011
    ..The aim of this study was to evaluate whether lymphopenia at diagnosis would have an adverse effect on survival in patients with PTCL-NOS treated with anthracycline-containing chemotherapy...